PF-4942847

an oral inhibitor of Hsp 90; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Triple Negative Breast Neoplasms 01/01/2017 - "Retraction: Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90." 08/15/2011 - "Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90."
2.	Neoplasms (Cancer) 08/15/2011 - "PF-4942847 induces degradation of multiple client proteins, cell-cycle block, apoptosis, and inhibits cell proliferation in TNBC lines, subsequently leading to tumor growth inhibition in mouse xenograft models. "

1.	Proteins (Proteins, Gene)